These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10859635)

  • 1. Aboulia: neurobehavioural dysfunction of dopaminergic system?
    Al-Adawi S; Dawe GS; Al-Hussaini AA
    Med Hypotheses; 2000 Apr; 54(4):523-30. PubMed ID: 10859635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Storage, recall, and novelty detection of sequences by the hippocampus: elaborating on the SOCRATIC model to account for normal and aberrant effects of dopamine.
    Lisman JE; Otmakhova NA
    Hippocampus; 2001; 11(5):551-68. PubMed ID: 11732708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The brain dopaminergic system. Pharmacological, behavioural and electrophysiological studies.
    Glenthøj BY
    Dan Med Bull; 1995 Feb; 42(1):1-21. PubMed ID: 7729164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence.
    Paredes RG; Agmo A
    Prog Neurobiol; 2004 Jun; 73(3):179-226. PubMed ID: 15236835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide as a physiopathological factor in neuropsychiatric disorders.
    Akyol O; Zoroglu SS; Armutcu F; Sahin S; Gurel A
    In Vivo; 2004; 18(3):377-90. PubMed ID: 15341194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of systems and networks of the limbic forebrain/limbic midbrain.
    Morgane PJ; Galler JR; Mokler DJ
    Prog Neurobiol; 2005 Feb; 75(2):143-60. PubMed ID: 15784304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midbrain dopamine system electrophysiological functioning: a review and new hypothesis.
    Bunney BS; Chiodo LA; Grace AA
    Synapse; 1991 Oct; 9(2):79-94. PubMed ID: 1821487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dopaminergic neurons and clinical neuropsychiatry].
    Ferrari E
    Acta Neurol (Napoli); 1992; 14(4-6):241-64. PubMed ID: 1293968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between excitatory amino acids and dopamine systems in the forebrain: implications for schizophrenia and Parkinson's disease.
    Iversen SD
    Behav Pharmacol; 1995 Aug; 6(5 And 6):478-491. PubMed ID: 11224356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of glucocorticoids in dopamine-related neuropsychiatric disorders.
    Van Craenenbroeck K; De Bosscher K; Vanden Berghe W; Vanhoenacker P; Haegeman G
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):10-22. PubMed ID: 16310935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mesolimbic and mesocortical pathways in Parkinson disease].
    Yokochi M
    Brain Nerve; 2007 Sep; 59(9):943-51. PubMed ID: 17886476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease.
    Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M
    Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.